Aerovate Therapeutics Stock (NASDAQ: AVTE) stock price, news, charts, stock research, profile.
You can purchase shares of Aerovate Therapeutics (NASDAQ:AVTE) through any online brokerage.
Other companies in Aerovate Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Serina Therapeutics (AMEX:SER), Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX) and Cellectar Biosciences (NASDAQ:CLRB).
Aerovate Therapeutics has a consensus price target of $11.75.
The stock price for Aerovate Therapeutics (NASDAQ: AVTE) is $2.49 last updated October 31, 2024 at 5:46 PM EDT.
There are no upcoming dividends for Aerovate Therapeutics.
Aerovate Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Aerovate Therapeutics.
Aerovate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.